Notably, our findings align conceptually with a pivotal prior study [47], which similarly reported decreased FREM1 expression in breast cancer tissues relative to normal controls and identified a correlation between low FREM1 levels and unfavorable prognosis, as well as enriched immune cell infiltration. This evidence concerns the gene FREM1 and breast cancer.